322 related articles for article (PubMed ID: 18248434)
21. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection.
Campbell TB; Fitzpatrick L; MaWhinney S; Zhang X; Schooley RT
J Acquir Immune Defic Syndr; 1999 Dec; 22(4):333-40. PubMed ID: 10634194
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
Szalai E; Gerlei Z; Szlávik J; Szládek G; Patel R; Hunyadi J; Gergely L; Juhász A
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):265-8. PubMed ID: 15681157
[TBL] [Abstract][Full Text] [Related]
23. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
24. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
25. Human herpesvirus 8 and human herpesvirus 2 infections in prison population.
Sarmati L; Babudieri S; Longo B; Starnini G; Carbonara S; Monarca R; Buonomini AR; Dori L; Rezza G; Andreoni M;
J Med Virol; 2007 Feb; 79(2):167-73. PubMed ID: 17177300
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of Kaposi's sarcoma-associated herpesvirus viremia during hematopoietic stem cell mobilization with filgrastim.
Neid JM; Schooley RT; Campbell TB
Am J Hematol; 2004 Dec; 77(4):410-2. PubMed ID: 15551282
[TBL] [Abstract][Full Text] [Related]
27. Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.
Núñez M; Machuca A; Soriano V; Podzamczer D; González-Lahoz J
AIDS; 2000 May; 14(8):913-9. PubMed ID: 10853972
[TBL] [Abstract][Full Text] [Related]
28. Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma.
Kumar N; McLean K; Inoue N; Moles DR; Scully C; Porter SR; Teo CG
J Med Virol; 2007 Jan; 79(1):52-9. PubMed ID: 17133549
[TBL] [Abstract][Full Text] [Related]
29. Human herpesvirus type 8 in HIV-infected patients with interstitial pneumonitis.
Müller A; Franzen C; Klussmann P; Wagner M; Diehl V; Fätkenheuer G; Salzberger B; Ablashi DV; Krueger GR
J Infect; 2000 May; 40(3):242-7. PubMed ID: 10908018
[TBL] [Abstract][Full Text] [Related]
30. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
31. Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.
Löw P; Neipel F; Rascu A; Steininger H; Manger B; Fleckenstein B; Kalden JR; Harrer T
Eur J Med Res; 1998 Oct; 3(10):461-4. PubMed ID: 9753702
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
33. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
34. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
[TBL] [Abstract][Full Text] [Related]
35. Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients.
Triantos D; Horefti E; Paximadi E; Kyriakopoulou Z; Karakassiliotis G; Papanastasiou K; Lelekis M; Panos G; Donta-Bakoyianni C; Rapidis A; Markoulatos P
Oral Microbiol Immunol; 2004 Jun; 19(3):201-4. PubMed ID: 15107073
[TBL] [Abstract][Full Text] [Related]
36. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
[TBL] [Abstract][Full Text] [Related]
38. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
[TBL] [Abstract][Full Text] [Related]
40. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission.
Brayfield BP; Kankasa C; West JT; Muyanga J; Bhat G; Klaskala W; Mitchell CD; Wood C
J Infect Dis; 2004 Jun; 189(12):2260-70. PubMed ID: 15181574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
